• Exchange: Helsinki
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ORNBV:FH

29.2400 EUR 0.0900 0.31%

As of 11:29:58 ET on 08/22/2014.

Snapshot for Orion OYJ (ORNBV)

Open: 29.1000 Day's Range: 28.9200 - 29.2600 Volume: 283,713
Previous Close: 29.1500 52wk Range: 17.2800 - 29.2600 1-Yr Rtn: +72.58%

Stock Chart for ORNBV

No chart data available.
  • ORNBV:FH 29.2400
  • 1D
  • 1M
  • 1Y
29.1500
Interactive ORNBV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORNBV

Current P/E Ratio (ttm) 18.2972
Estimated P/E(12/2014) 19.5455
Relative P/E vs. HEXP 0.6750
Earnings Per Share (EUR) (ttm) 1.5981
Est. EPS (EUR) (12/2014) 1.4960
Est. PEG Ratio -
Market Cap (M EUR) 4,116.73
Shares Outstanding (M) 99.89
30 Day Average Volume 273,977
Price/Book (mrq) 8.8620
Price/Sale (ttm) 3.9928
Dividend Indicated Gross Yield 4.28%
Cash Dividend (EUR) 1.2500
Dividend Ex-Date 03/26/2014
5 Year Dividend Growth 5.64%
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORNBV

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ORNBV

Orion Oyj develops and manufactures pharmaceuticals and diagnostic kits. The Company produces hormone therapies and drugs to treat central nervous system disorders, cardiovascular diseases and urological disorders, and in vitro diagnostic kits used in doctor's offices and small laboratories.

Hannu SyrjaenenChairmanJukka YlppoVice Chairman
Timo LappalainenPresident/CEOJari KarlsonChief Financial Officer
More Company Profile & Key Executives for ORNBV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil